Sensible SEND Blog

BiotechCentrusCROData IntegrationPharmaceuticalPre-ClinicalRegulatory SubmissionSENDSEND Advantage ServicesSensible SEND

Metadata Magic! Data Warehousing with SEND

Marc Ellison

Dr Brenda Finney shares her thoughts on the use of SEND for data exchange in data warehouses like our Centrus platform which is built on the ToxHub database.

BiotechCROPharmaceuticalPre-ClinicalRegulatory SubmissionRegulatory SubmissionsSENDSEND Advantage ServicesSensible SENDSubmit

Stop me if you’ve heard this one before…

Marc Ellison

In the world of SEND, there are main topics that keep reoccurring. Subjects that need revisiting partly with fresh impetus but mainly because these are the things that keep cropping up and become the main...

BiotechCROPharmaceuticalPre-ClinicalRegulatory ComplianceRegulatory SubmissionSENDSEND Advantage ServicesSensible SENDSubmit

Submission implications of the new SEND standards

Marc Ellison

In this post we discuss the submission implications of the publication of the new implementation guides for SENDIG-Genetox v1.0 and SENDIG-DART v1.2.

BiotechCROPharmaceuticalPre-ClinicalRegulatory SubmissionRegulatory SubmissionsSENDSEND Advantage ServicesSensible SENDSubmit

New SEND standards from CDISC

Marc Ellison

The SENDIG-DART v1.2 and SENDIG-Genetox v1.0 Implementation Guides (IGs) plus their accompanying Conformance Rules are published.

Artificial Intelligence and Machine LearningBiotechCRODiscoveryPharmaceuticalPre-ClinicalPredictive ToxicologyRegulatory SubmissionSENDSensible SEND

Risk Aversion in the Age of Change

Marc Ellison

We work in a highly risk-averse industry where even software upgrades are approached cautiously. SEND has driven huge change, but now AI and predictive toxicology are pushing boundaries even further. How do we balance risk...

Stay up to Date

Get expert tips, industry news, and fresh content delivered to your inbox.